Anticipates Record Q4 2021 and Q1 2022 Revenues and Profits Garden City, NY, Feb. 16, 2022 (GLOBE NEWSWIRE) — ProPhase Labs, Inc. (NASDAQ: PRPH), a diversified biotech and genomics company, announced today that its Board of Directors has declared a special cash dividend in the amount of $0.30 per share on its common stock, payable on March 10, 2022 to stockholders of record as of March 1, 2022. “Given our strong projected financial performance in net income and EBITDA for the fourth quarter of


